immunoforge

ImmuneAGE

This company develops a drug discovery platform for creating therapies that rejuvenate the immune system by targeting hematopoietic stem cells in the bone marrow.

Toleranzia

This company develops drugs using an immune tolerance platform to treat patients with rare autoimmune diseases, such as myasthenia gravis.

Immunis

This biotechnology company develops stem cell-derived secretome therapies to treat age-related immune dysfunction and muscle wasting for patients with sarcopenia and metabolic diseases.

Juvena Therapeutics

This biotechnology company develops protein-based regenerative medicines for patients with chronic muscle and metabolic diseases.

Ra Pharma

This biotech company develops synthetic macrocyclic peptide therapeutics for patients with rare complement-mediated diseases such as myasthenia gravis.

Immusoft

This clinical-stage biotechnology company develops engineered B cell therapies to treat patients suffering from rare inherited metabolic disorders and other chronic diseases.

immunique

This company develops immune therapeutics, including cell therapies and peptides, for patients with cancer and autoimmune diseases.

Avexegen

This biopharmaceutical company develops peptide therapies to treat gastrointestinal disorders and restore gut health for patients with inflammatory conditions.